APPLICATION
ANDA040187
TYPE
ANDA
ORIGINAL APPROVAL
1997-08-28
LATEST ACTION
2025-01-22
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Discontinued
Products
THIORIDAZINE HYDROCHLORIDEDiscontinued
THIORIDAZINE HYDROCHLORIDE 30MG/ML · CONCENTRATE · ORAL
Approval history
2025-01-22Labeling · Supplement 5 · standardAP
2017-02-23Labeling · Supplement 4 · standardAP
2010-12-06Labeling · Supplement 3AP
2002-10-31Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.